Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?
- PMID: 20167003
- DOI: 10.2174/1874609811003020113
Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?
Abstract
Over the last decades estrogen has been recognized to be involved in normal brain function due to its neurothrophic and neuroprotective effects. Estrogen is intimately associated with neuronal survival, mitochondrial function, neuroinflammation and cognition through genomic as well as non-genomic pathways. It is also known that the neuroprotective actions mediated by estrogens are interlinked with the insulin-like growth factor-1 (IGF-1) signaling pathway. This review is mainly devoted to explore the physiological and pathophysiological effects of estrogen and its signaling pathways in the brain. The molecular mechanisms underlying these effects are also debated. Finally, we discuss the potential neuroprotection afforded by estrogens in Alzheimer's disease pathophysiology focusing in the "window of opportunity" for the initiation of estrogen therapy as a critical factor in the fight against neurodegeneration.
Similar articles
-
Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection.Brain Res Brain Res Rev. 2001 Nov;37(1-3):320-34. doi: 10.1016/s0165-0173(01)00137-0. Brain Res Brain Res Rev. 2001. PMID: 11744097 Review.
-
Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.BMC Neurosci. 2006 Mar 13;7:24. doi: 10.1186/1471-2202-7-24. BMC Neurosci. 2006. PMID: 16533397 Free PMC article.
-
Non-feminizing estrogens: a novel neuroprotective therapy.Mol Cell Endocrinol. 2014 May 25;389(1-2):40-7. doi: 10.1016/j.mce.2013.12.017. Epub 2014 Jan 11. Mol Cell Endocrinol. 2014. PMID: 24424441 Free PMC article. Review.
-
Novel mechanisms for estrogen-induced neuroprotection.Exp Biol Med (Maywood). 2006 May;231(5):514-21. doi: 10.1177/153537020623100505. Exp Biol Med (Maywood). 2006. PMID: 16636299 Review.
-
Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia.J Neurosci Res. 2005 Sep 1;81(5):653-65. doi: 10.1002/jnr.20583. J Neurosci Res. 2005. PMID: 16013043
Cited by
-
Estrogen receptor-β of microglia underlies sexual differentiation of neuronal protection via ginsenosides in mice brain.CNS Neurosci Ther. 2018 Oct;24(10):930-939. doi: 10.1111/cns.12842. Epub 2018 Mar 9. CNS Neurosci Ther. 2018. PMID: 29524300 Free PMC article.
-
A novel mouse model of Alzheimer's disease with chronic estrogen deficiency leads to glial cell activation and hypertrophy.J Aging Res. 2011;2011:251517. doi: 10.4061/2011/251517. Epub 2011 Sep 28. J Aging Res. 2011. PMID: 21969914 Free PMC article.
-
Sex differences in risk of Alzheimer's disease in adults with Down syndrome.Alzheimers Dement (Amst). 2020 Sep 13;12(1):e12084. doi: 10.1002/dad2.12084. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 32995462 Free PMC article.
-
Mitigating Effect of Estrogen in Alzheimer's Disease-Mimicking Cerebral Organoid.Front Neurosci. 2022 Mar 24;16:816174. doi: 10.3389/fnins.2022.816174. eCollection 2022. Front Neurosci. 2022. PMID: 35401074 Free PMC article.
-
Elucidation of Pharmacological Mechanism Underlying the Anti-Alzheimer's Disease Effects of Evodia rutaecarpa and Discovery of Novel Lead Molecules: An In Silico Study.Molecules. 2023 Aug 3;28(15):5846. doi: 10.3390/molecules28155846. Molecules. 2023. PMID: 37570816 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous